23. SYSTEMATIC REVIEW OF THE COST - EFFECTIVENESS OF PEMBROLIZUMAB IN RECURRENT OR METASTATIC CERVICAL CANCER. (2025). Vietnam Journal of Community Medicine, 66(CĐ8-NCKH). https://doi.org/10.52163/yhc.v66iCD8.2569